DE3177239D1 - 4-brommethyl-5-methyl-1,3-dioxolen-2 -on und verfahren zu seiner herstellung. - Google Patents

4-brommethyl-5-methyl-1,3-dioxolen-2 -on und verfahren zu seiner herstellung.

Info

Publication number
DE3177239D1
DE3177239D1 DE8787103766T DE3177239T DE3177239D1 DE 3177239 D1 DE3177239 D1 DE 3177239D1 DE 8787103766 T DE8787103766 T DE 8787103766T DE 3177239 T DE3177239 T DE 3177239T DE 3177239 D1 DE3177239 D1 DE 3177239D1
Authority
DE
Germany
Prior art keywords
dioxolen
group
methyl
chem
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787103766T
Other languages
English (en)
Inventor
Fumio Sakamoto
Shoji Ikeda
Goro Tsukamoto
Isamu Utsumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Application granted granted Critical
Publication of DE3177239D1 publication Critical patent/DE3177239D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34—Oxygen atoms
    • C07D317/40—Vinylene carbonate; Substituted vinylene carbonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE8787103766T 1980-04-30 1981-04-29 4-brommethyl-5-methyl-1,3-dioxolen-2 -on und verfahren zu seiner herstellung. Expired - Fee Related DE3177239D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55058510A JPS6019908B2 (ja) 1980-04-30 1980-04-30 １，３−ジオキソレン−２−オン誘導体

Publications (1)

Publication Number Publication Date
DE3177239D1 true DE3177239D1 (de) 1991-02-07

Family

ID=13086410

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8181103232T Expired DE3167908D1 (de) 1980-04-30 1981-04-29 Use of 1,3-dioxolen-2-one derivatives
DE8787103766T Expired - Fee Related DE3177239D1 (de) 1980-04-30 1981-04-29 4-brommethyl-5-methyl-1,3-dioxolen-2 -on und verfahren zu seiner herstellung.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8181103232T Expired DE3167908D1 (de) 1980-04-30 1981-04-29 Use of 1,3-dioxolen-2-one derivatives

Country Status (7)

Country Link
US (1) US4342693A (de)
EP (3) EP0090344B1 (de)
JP (1) JPS6019908B2 (de)
AT (3) ATE59646T1 (de)
AU (1) AU536686B2 (de)
CA (1) CA1168251A (de)
DE (2) DE3167908D1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5869876A (ja) * 1981-07-13 1983-04-26 メルク・エンド・カムパニ−・インコ−ポレ−テツド （５−アルキル−２−オキソ−１，３−ジオキソレン−４−イル）メチルエステル基を用いたカルボン酸医薬の経口吸収増大
GR76525B (de) * 1981-07-13 1984-08-10 Merck & Co Inc
US4654331A (en) * 1981-07-13 1987-03-31 Merck & Co., Inc. Oral absorption enhancement of carboxylic acid pharmaceuticals using (5-alkyl-2-oxo-1,3-dioxolen-4-yl)methyl ester group
US4479947A (en) * 1981-07-13 1984-10-30 Merck & Co., Inc. Oral absorption enhancement of carboxylic acid pharmaceuticals using (5-alkyl-2-oxo-1,3-dioxolen-4-yl)methyl ester group
JPS5874677A (ja) * 1981-10-30 1983-05-06 Kanebo Ltd 臭素化１，３−ジオキソレン−２−オン類の製造法
JPS5921692A (ja) * 1982-07-29 1984-02-03 Sankyo Co Ltd 経口ペネム化合物及びその製法
US4555579A (en) * 1983-03-24 1985-11-26 E. R. Squibb & Sons, Inc. Dioxolenylmethyl ester prodrugs of phosphinic acid ace inhibitors
JPS59212488A (ja) * 1983-05-18 1984-12-01 Kyoto Yakuhin Kogyo Kk ジオキソ−ル誘導体
US4536393A (en) * 1983-06-06 1985-08-20 Pfizer Inc. 6-(Aminomethyl)penicillanic acid 1,1-dioxide esters and intermediates therefor
JPS59231082A (ja) * 1983-06-14 1984-12-25 Kanebo Ltd ４−クロロ−４−メチル−５−メチレン−１，３−ジオキソラン−２−オン
US4521533A (en) * 1984-07-12 1985-06-04 Pfizer Inc. Salts of 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide esters and beta-lactam antibiotics
US4675186A (en) 1985-04-18 1987-06-23 Pfizer Inc. 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
US4777267A (en) * 1986-02-07 1988-10-11 Kanebo Ltd. 1,3-dioxol-2-one derivatives
US4985456A (en) * 1986-08-07 1991-01-15 Mikasa Seiyaku Co., Ltd. 2-anilinophenylacetic acid derivative
EP0544907B1 (de) * 1990-08-20 1999-10-27 Suntory Limited Antibakterielle penem-esterderivate
US5703068A (en) * 1990-08-20 1997-12-30 Suntory Limited Penem compounds
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
JP3501484B2 (ja) * 1992-12-17 2004-03-02 三共株式会社 ビフェニル誘導体
DE19920551A1 (de) * 1999-05-05 2000-11-09 Bayer Ag Substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen
WO2008059367A1 (en) * 2006-11-14 2008-05-22 Pfizer Products Inc. Penem prodrugs
CN104230878A (zh) * 2014-09-26 2014-12-24 六安科瑞达新型材料有限公司 4-氯甲基-5-甲基-1,3-二氧杂环戊烯-2-酮的制备方法
CN115772150A (zh) * 2022-11-10 2023-03-10 广州理文科技有限公司 一种碳酸乙烯酯氟代衍生物的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3020290A (en) * 1959-10-14 1962-02-06 Jefferson Chem Co Inc Preparation of unsaturated compounds

Also Published As

Publication number Publication date
ATE10939T1 (de) 1985-01-15
ATE59646T1 (de) 1991-01-15
US4342693A (en) 1982-08-03
EP0039477A1 (de) 1981-11-11
AU536686B2 (en) 1984-05-17
EP0090344B1 (de) 1988-05-25
DE3167908D1 (de) 1985-02-07
ATE34572T1 (de) 1988-06-15
JPS6019908B2 (ja) 1985-05-18
EP0237084A3 (en) 1987-09-30
AU6998881A (en) 1981-11-05
CA1168251A (en) 1984-05-29
EP0237084B1 (de) 1991-01-02
EP0039477B1 (de) 1984-12-27
EP0237084A2 (de) 1987-09-16
JPS5726684A (en) 1982-02-12
EP0090344A1 (de) 1983-10-05

Similar Documents

Publication Publication Date Title
DE3177239D1 (de) 4-brommethyl-5-methyl-1,3-dioxolen-2 -on und verfahren zu seiner herstellung.
ATE67497T1 (de) Verfahren zur herstellung von thiazolidinedionderivaten.
ATE87925T1 (de) Erythromycin-a-derivate und verfahren zu ihrer herstellung.
ATE164582T1 (de) 1-methylcarbapenemderivate und verfahren zu ihrer herstellung
DE3767351D1 (de) Sialosylceramide und verfahren zu deren herstellung.
DE3882438D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
ATE77818T1 (de) Neue naphthylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung.
ATE8045T1 (de) Azolylalkyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ATE57183T1 (de) Herstellung von substituierten gammabutyrolactonen, verwendbar als zwischenprodukte zur herstellung von fungiziden imidazolen und triazolen.
ATE115567T1 (de) Verfahren zur herstellung von halogensulfonyl- substituierten pyridinen.
ATE18667T1 (de) Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung.
ATE82292T1 (de) Verfahren zur herstellung von 2-alpha-methyl-2beta-(1,2,3-triazol-1-yl)methylpenam-3-alphacarbons|urederivaten.
DE3866148D1 (de) Chinolincarbonsaeure-derivate, diese enthaltende zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
ATE27606T1 (de) 7-alpha-acylthio-15,16-methylen-3-oxo-17-alphapregna-1,4-dien-21,17-carbolaktone, verfahren zu deren herstellung und verwendung in arzneimitteln.
ATE38665T1 (de) Verfahren zur herstellung von 5-perfluoralkyl-5,6-dihydrouracyl-derivaten und verwendbare zwischenprodukte.
DE69119714D1 (de) Verfahren zur Herstellung von Benzylphthalazinonderivaten und von deren Salzen
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
ATE28749T1 (de) Verfahren zur herstellung von 3,4-dihydro-alpha- pyronen.
ATE135693T1 (de) Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung
DE68907857D1 (de) Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE222T1 (de) Bis-(2,4-dinitrophenyl)-m ethyl-pyridinium-verbindungen, verfahren zu ihrer herstellung und ihre verwendung als ph-indikatoren.
ATE36321T1 (de) (bis(substituiertes methyl)methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
ATE159939T1 (de) Verfahren und zwischenprodukte für die herstellung von 6-fluorbenzisothiazolen
ATE17851T1 (de) Imidazolylkarbonsaeure, deren derivate und herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee